arrow
Back
P

Pier Luigi Zinzani

universita di bologna

117H-index
1.8KPaper Count
6.1WCitation Count
Published Papers 360
Publication Date
Early Integration of CAR T-Cell Therapy in Mantle Cell Lymphoma: Expert Opinion in the Era of BTK Inhibitors
err2026-10-10
err0
errOAAI
errCarlo Visco; Stefania Bramanti; Paolo Corradini; Enrico Derenzini; Pier Luigi Zinzani
errShare
errSave
BEAM versus EAM, FEAM, BeEAM, and TEAM: exploring conditioning strategies in autologous stem cell transplantation for Hodgkin lymphoma a retrospective study of the LWP of EBMT
err2026-10-06
err0
PREAI
errAnnalisa Paviglianiti; Mathilde Fekom; Khalid Halahleh; Malek Benakli; Mahmoud Aljurf; Sebastian Giebel; Pierluigi Zinzani; Raffaella Cerretti; Krimo Bouabdallah; Jean El-Cheikh; Saveria Capria; Christof Scheid; Maurizio Musso; Anne Huynh; Hervé Ghesquieres; Charalampia Kyriakou; Alina Tanase; Anna Sureda; Ali Bazarbachi
errShare
errSave
Consensus-Based Ranking of Determinants for Frontline Therapy Selection in Chronic Lymphocytic Leukemia: A Conjoint Analysis
err2026-08-23
err0
PREAI
errMarta Coscia; Gianluca Gaidano; Paolo Ghia; Luca Laurenti; Monia Marchetti; Paolo Sportoletti; Alessandra Tedeschi; Pier Luigi Zinzani
errShare
errSave
Correction to: Modern and multidisciplinary care in polycythemia vera
err2026-07-25
err0
errOAAI
errFrancesca Palandri; Chiara Sartor; Alessandro Pileri; Olga Addimanda; Christian Gagliardi; Michelangelo Sartori; Monica Benni; Maddalena Giannella; Federica Lo Dato; Elena Sabattini; Lorenzo Fiorino; Alessandra Dedola; Filippo Branzanti; Maria B. Rondinelli; Massimo Reta; Nazzareno Galiè; Pierluigi Viale; Benilde Cosmi; Michelangelo La Placa; Maria C. Morelli; Pier Luigi Zinzani
errShare
errSave
Short BRAF+MEK coinhibition, alone and combined with anti-CD20 immunotherapy, in relapsed or refractory hairy cell leukemia: An investigator-sponsored multi-center phase 2 clinical trial
err2026-07-09
err0
errOAAI
errLuca De Carolis; Monia Capponi; Alessandro Mancini; Flavio Falcinelli; Caterina Stelitano; Alessandro Pulsoni; Edoardo Simonetti; Alessandra Romano; Gianna Maria D'Elia; Jacopo Olivieri; Maria Paola Martelli; Alessandra Pucciarini; Alessia Santi; Marta Naccari; Alessandra Venanzi; Antonio Bennati; Pier Luigi Zinzani; Marzia Varettoni; Simone Ferrero; Massimo Pini; Robin Foà; Elisa Lucchini; Maurizio Frezzato; Brunangelo Falini; Enrico Tiacci
errShare
errSave
Fixed-duration pirtobrutinib plus venetoclax–rituximab versus venetoclax–rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial
err2026-07-09
err0
errOAAI
errMatthew S Davids; Toby A Eyre; Jennifer A Woyach; Lindsey E Roeker; Alessandra Ferrajoli; Yucai Wang; Constantine S Tam; Wojciech Jurczak; Pier Luigi Zinzani; Martin Šimkovič; Jian-Yong Li; Francesc Bosch; Damien Roos-Weil; Paula Cramer; Anders Osterborg; Prioty Islam; Ryan Jacobs; Alan Skarbnik; Seema A Bhat; Suhyun Kang
errShare
errSave
First-line ibrutinib plus venetoclax for non-blastoid mantle cell lymphoma in patients ≥65 years or with TP53 mutations
errBlood
IF23.1
err2026-07-03
err0
errOAAI
errMichael Wang; Marc Hoffmann; Tomasz Wrobel; Marek Trneny; David Belada; Fatih Demirkan; Panayiotis Panayiotidis; Wojciech Jurczak; Pier Luigi Zinzani; Mary-Margaret Keating; Sung-Soo Yoon; Miklós Egyed; Constantine S. Tam; Nathalie A. Johnson; Edith Szafer-Glusman; Jennifer Lin; James P. Dean; Jutta K. Neuenburg; Gottfried von Keudell
errShare
errSave
LY08 Real-world outcomes and survival with targeted and established systemic therapies in advanced-stage cutaneous T-cell lymphoma: an updated PROCLIPI analysis
err2026-06-26
err0
errOAAI
errElizabeth Peterknecht; Abraham Bashir; Evangelina Papadavid; Alejandro Gru; Sean Whittaker; Christiane Querfeld; Maarten Vermeer; Emmilia Hodak; Martine Bagot; Pietro Quaglino; Octavio Servitje; Egle Ramelyte; Jose Sanches; Henry M Prince; Richard Cowan; Rudolf Stadler; Emmanuella Guenova; Anne-Marie Busschots; Oleg Akilov; Ulrike Wehkemp; Teresa Estrach; Sophie Weatherhead; Emilio Berti; Aikaterini Patsatsi; Annamari Ranki; Constanze Jonak; Pablo Ortiz-Romero; Marta Marschalko; Rubeta N Matin; Franz Trautinger; Giles Dunnill; Claus-Detlev Klemke; Mike Bayne; Cesare Massone; Ramon Pujol; Rachel Wachsmuth; Stephanie Schulz; Luke Bennett; Paula Enz; Marion Wobser; Larisa Geskin; Marie Beylot-Barry; Jan P Nicolay; Mona A Ibrahim; Arvind Aruimainathan; Pam Mackay; Jess Bailey; Deborah Turner; Pier L Zinzani; Nicola Pimpinelli; Felicity Evison; Maxime Battistella; Werner Kempf; Lorenzo Cerroni; Rein Willemze; Youn Kim; Julia Scarisbrick
errShare
errSave
The prognostic role of interim [18F]FDG PET/CT in Diffuse Large B cell lymphoma: an updated systematic review and meta-analysis
err2026-06-15
err0
errOAAI
errDomenico Albano; Stephane Chauvie; Alessio Rizzo; Francesco Bertagna; Beatrice Casadei; Umberto Vitolo; Alessandra Tucci; Pier Luigi Zinzani; Luca Guerra
errShare
errSave
Occult hepatitis B virus infection status is not associated with impaired efficacy of anti-CD19 CAR-T-cell therapy for lymphoma and shows a distinct immune toxicity profile: Results from the CART-SIE study
err2026-05-21
err0
errOAAI
errNicola Polverelli; Annalisa Chiappella; Cristiana Carniti; Pierluigi Zinzani; Maurizio Musso; Maria Chiara Tisi; Fabio Ciceri; Ilaria Cutini; Armando Santoro; Patrizia Chiusolo; Anna Maria Barbui; Mirko Farina; Livia Donzelli; Lucia Brunello; Massimo Martino; Mauro Krampera; Alessia Castellino; Giovanni Grillo; Barbara Botto; Jacopo Olivieri; Michele Clerico; Pellegrino Musto; Attilio Olivieri; Antonio Bianchessi; Irene Defrancesco; Giulia Losi; Caterina Zerbi; Gianluca Martini; Elisa Roncoroni; Manuel Gotti; Maria Grazia Benevento; Alessia Taurino; Anna Fedina; Paolo Corradini; Luca Arcaini
errShare
errSave
Frontline nilotinib vs dasatinib in NEwly diagnosed chronic phase chronic myeloid leukemia: a propensity score analysis based on AIFA monitoring registries
err2026-04-24
err0
PREAI
errMassimo Breccia; Simone Celant; Fabrizio Pane; Alessandra Iurlo; Valentina Summa; Paolo Corradini; Pierluigi Zinzani; Pier Paolo Olimpieri
errShare
errSave
Modern and multidisciplinary care in polycythemia vera
err2026-04-18
err0
errOAAI
errFrancesca Palandri; Chiara Sartor; Alessandro Pileri; Olga Addimanda; Christian Gagliardi; Michelangelo Sartori; Monica Benni; Maddalena Giannella; Federica Lo Dato; Elena Sabattini; Lorenzo Fiorino; Alessandra Dedola; Filippo Branzanti; Maria B. Rondinelli; Massimo Reta; Nazzareno Galiè; Pierluigi Viale; Benilde Cosmi; Michelangelo La Placa; Maria C. Morelli; Pier Luigi Zinzani
errShare
errSave
Acalabrutinib in Waldenström macroglobulinemia yields durable responses with 5 years of follow-up
err2026-04-17
err0
errOAAI
errRoger G. Owen; Helen McCarthy; Shirley D’Sa; Sheeba K. Thomas; Olivier Tournilhac; Francesco Forconi; Marie José Kersten; Pier Luigi Zinzani; Sunil Iyengar; Jaimal Kothari; Monique C. Minnema; Efstathios Kastritis; Bruce D. Cheson; Harriet S. Walter; Daniel Greenwald; Roser Calvo; Yi Li; Simon Rule; Richard R. Furman
errShare
errSave
A Real-Life Multicenter Study of Checkpoint Inhibitors in Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma
err2026-04-10
err0
PREAI
errGabriele Gugliotta; Lisa Argnani; Martina Cantelli; Antonio Pinto; Ausilia Gorgone; Francesco Piazza; Claudio Fozza; Vincenza Fernanda Fesce; Fabrizio Marino; Melania Celli; Elsa Pennese; Francesco Gaudio; Pietro Lauzzana; Luca Pezzullo; Sonya De Lorenzo; Paulina Maria Nierychlewska; Giusy Ceparano; Fabrizio Pane; Beatrice Casadei; Cinzia Pellegrini; Claudia Romano; Pier Luigi Zinzani
errShare
errSave
Correction: Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years’ follow-up
err2026-01-28
err0
errOAAI
errEva Domingo-Domènech; Barbara Pro; Tim Illidge; Steven Horwitz; Lorenz Trumper; Swami Iyer; Ranjana Advani; Nancy L. Bartlett; Jacob Haaber Christensen; Won-Seog Kim; Tatyana Feldman; Ilseung Choi; Giuseppe Gritti; David Belada; Andrei Shustov; Arpad Illes; Pier Luigi Zinzani; Andreas Hüttmann; Marek Trneny; Steven Le Gouill; Deepa Jagadeesh; Jonathan W. Friedberg; Meredith Little; Cassie Dong; Michelle Fanale; Keenan Fenton; Kerry J. Savage
errShare
errSave
Polatuzumab Vedotin and Glofitamab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in the Compassionate Use Program in Italy
err2025-12-14
err0
errOAAI
errZinzani, Pier Luigi; Dell'Omo, Giulia; Fusco, Letizia; Peduto, Ilaria; Galeone, Carlotta; Cavallo, Federica; Gritti, Giuseppe
errShare
errSave
Nivolumab plus brentuximab vedotin for relapsed/refractory diffuse large B-cell lymphoma
err2025-12-10
err0
errOAAI
errNathalie A. Johnson; Pier Luigi Zinzani; Eva Domingo-Domenech; Joshua Brody; Justin Kline; Bijal Dinesh Shah; Amitkumar Nitinkumar Mehta; Herve Ghesquieres; Kerry J. Savage; Paul M. Barr; Armando Santoro; Silvia Ferrari; David Cunningham; Graham P. Collins; Michelle Fanale; Jennifer Krajewski; Alev Akyol; Russell Crowe; Rachael Wen; John Kuruvilla
errShare
errSave
Early time-to-relapse as a survival prognosticator in mature T-cell/NK-cell lymphomas: results from the PETAL Consortium
errBlood
IF23.1
err2025-12-08
err0
errOAAI
errMark N Sorial; Luis E Malpica Castillo; Carlos Chiattone; Edith Julia; Emmanuel Bachy; Stefan K Barta; Robert Stuver; Eric Jacobsen; Massimo Federico; Hasmukh Jain; Henry Miles Prince; Francine Foss; Pier Luigi Zinzani; Takeshi Okatani; Won-Seog Kim; Estelle Verburgh; Mubarak Al-Mansour; Maria Elena Cabrera; Govind Bhagat; Changyu Shen
errShare
errSave